Agency Forms Undergoing Paperwork Reduction Act Review, 78737-78738 [2015-31706]

Download as PDF 78737 Federal Register / Vol. 80, No. 242 / Thursday, December 17, 2015 / Notices Surveillance System, a unique source of longitudinal information on U.S. mines and their employees. Its purpose will be to: (1) Track changes and emerging trends over time; (2) provide current data to guide research and training activities; (3) provide updated demographic and occupational data for the mining workforce; and (4) provide denominator data to help understand the risk of work-related injuries, disease, and fatalities in specific demographic and occupational subgroups. The goal of the proposed project is to improve its surveillance capability related to the occupational risks in mining. NIOSH is requesting a three-year approval for this data collection. NIOSH is planning to use the Mining Industry and Workforce Survey (MIWS) to collect data for the Mining Industry Surveillance System. Data will be collected through surveys conducted on a rotating basis in mining sectors aligned with national mining association. In Phase 1 of the project, the MIWS will be conducted in the stone/sand and gravel mining sector in year 1, the metal/nonmetal mining sector in year 2, and the coal mining sector in year 3. Data from this survey will provide denominator data so that accident, injury, and illness reports can be evaluated in relation to the population at risk. Additionally, NIOSH cannot separately determine the number of contractor employees working in metal, nonmetal, stone, or sand and gravel mines. The survey will collect minelevel data on contractor employees to allow NIOSH to determine the quantity of contract labor that mine operators use and the type of work these employees perform. NIOSH will also use the MIWS to collect mine-level data that will provide a valuable picture of the current working environment (work schedules and shift work practices) used in the U.S. mining industry. Based on the stratification and sample size allocation plan developed for this project, 34% of all sampled mines have fewer than 10 employees. Mines with 10 or fewer employees will not have to do any sampling as they will be asked to provide data for all of their employees. Small mines will require up to 45 minutes to complete the survey. Mines with 11 or more employees will need up to 1.5 hours given their need to generate an employee roster and sample 10 of their employees. Thus, NIOSH is estimating that the average annual burden to complete the survey will be 1 hour. Non-responding mines will be asked to complete the Nonresponse Survey which consists of only seven questions. NIOSH estimates that the burden for this brief survey will be 10 minutes or less. The total estimated burden hours are 1,397. There is no cost to the respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Avg. burden per response (in hrs.) Total burden (in hrs.) Type of respondents Form name Responding Stone/Sand & Gravel Mines (Year 1). Nonresponding Stone/Sand & Gravel Mines (Year 1). Responding Metal/Nonmetal Mines (Year 2). Nonresponding Metal/Nonmetal Mines (Year 2). Responding Coal Mines (Year 3) ..... Nonresponding Coal Mines (Year 3) Mining Industry & Workforce Survey 526 1 1 526 Nonresponse Survey ........................ 350 1 10/60 58 Mining Industry & Workforce Survey 369 1 1 369 Nonresponse Survey ........................ 246 1 10/60 41 Mining Industry & Workforce Survey Nonresponse Survey ........................ 363 242 1 1 1 10/60 363 40 Total ........................................... ........................................................... ........................ ........................ ........................ 1,397 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2015–31741 Filed 12–16–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES asabaliauskas on DSK5VPTVN1PROD with NOTICES Centers for Disease Control and Prevention [30Day–16–0009] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in VerDate Sep<11>2014 16:53 Dec 16, 2015 Jkt 238001 accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. E:\FR\FM\17DEN1.SGM 17DEN1 78738 Federal Register / Vol. 80, No. 242 / Thursday, December 17, 2015 / Notices Proposed Project National Disease Surveillance Program–I—Case Reports—Revision— National Center for Emerging and Zoonotic Infectious Disease (NCEZID), Centers for Disease Control and Prevention (CDC) Background and Brief Description Surveillance of the incidence and distribution of disease has been an important function of the US Public Health Service (PHS) since an 1878 Act of Congress, which authorized the PHS to collect morbidity reports. After the Malaria Control in War Areas Program had fulfilled its original 1942 objective of reducing malaria transmission, its basic tenets were carried forward and broadened by the formation of the Communicable Disease Center (CDC) in 1946. CDC was conceived of as a wellequipped, broadly staffed agency used to translate facts about analysis of morbidity and mortality statistics on communicable diseases and through field investigations. The surveillance emphasis has shifted as certain diseases have declined in incidence, national emergencies have prompted involvement in new areas, and other diseases have taken on new aspects. Surveillance for the following diseases was approved three years ago: Creutzfeldt-Jakob Disease (CJD), Cyclosporiasis cayetanensis, Q Fever, Dengue, Reye Syndrome, Hantavirus pulmonary syndrome (HPS), Tick-borne Rickettsial Disease, Kawasaki syndrome, Trichinosis, Legionellosis, Tularemia, Lyme Disease (LD), Typhoid Fever, Malaria, Viral Hepatitis, and Plague. Due to change requests and surveillance systems moving to and receiving information collection approval under OMB Control number 0920–0728 (National Notifiable Diseases Surveillance System (NNDSS)) during the last three years, the following diseases/conditions are now included in this program: Creutzfeldt-Jakob Disease (CJD), Reye Syndrome, Kawasaki syndrome, and Acute Flaccid Myelitis. CDC needs to continue this surveillance package for another three years to maintain continuity in these surveillance systems. The data throughout the years are used to monitor the occurrence of non-notifiable conditions and to plan and conduct prevention and control programs at the state, territorial, local and national levels. CDC currently collects data for certain diseases in summary form under OMB Control number 0920–0004, (National Disease Surveillance Program II— Disease Summaries). These disease summaries are for important, yet different types of infections from those covered in this disease case reports request. Maintaining separate OMB Control number approvals for these two types of data collections assists CDC in managing the two surveillance activities. CDC works with state health departments to propose, coordinate, and evaluate nationwide surveillance systems. State epidemiologists are responsible for the collection, interpretation, and transmission of medical and epidemiological information to CDC. The original purpose for reporting communicable diseases was to determine the prevalence of diseases dangerous to public health. However, collecting data also provided the basis for planning and evaluating effective programs for prevention and control of infectious diseases. Current information on disease incidence is needed to study present and emerging disease problems. CDC coordination of nationwide reporting maintains uniformity so that comparisons can be made from state to state and year to year. In addition to development of prevention and control programs, surveillance data serves as statistical material for those engaged in research or medical practice, aid to health education officials and students, and data for manufacturers of pharmaceutical products. Annual surveillance data are published in the MMWR Surveillance Summary. The total burden requested is 190 hours, a decrease in 11,257 hours since the last submission. This is due to the other diseases reporting moving to the Notifiable Diseases Surveillance System (0920–0728). There is no cost to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents Epidemiologist Epidemiologist Epidemiologist Epidemiologist Number of respondents Form name Number of responses per respondent Average burden per response (in hrs.) ................................................. ................................................. ................................................. ................................................. CJD ................................................................ Kawasaki Syndrome ...................................... Reye Syndrome ............................................. Acute Flaccid Myelitis .................................... 20 55 50 100 2 8 1 1 20/60 15/60 20/60 30/60 Total ......................................................... ......................................................................... ........................ ........................ ........................ asabaliauskas on DSK5VPTVN1PROD with NOTICES Leroy Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2015–31706 Filed 12–16–15; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–16–0821; Docket No. CDC–2015– 0114] BILLING CODE 4163–18–P Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: VerDate Sep<11>2014 16:53 Dec 16, 2015 Jkt 238001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 ACTION: Notice with comment period. The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed revision of an information collection request entitled SUMMARY: E:\FR\FM\17DEN1.SGM 17DEN1

Agencies

[Federal Register Volume 80, Number 242 (Thursday, December 17, 2015)]
[Notices]
[Pages 78737-78738]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-31706]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-16-0009]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

[[Page 78738]]

Proposed Project

National Disease Surveillance Program-I--Case Reports--Revision--
National Center for Emerging and Zoonotic Infectious Disease (NCEZID), 
Centers for Disease Control and Prevention (CDC)

Background and Brief Description

    Surveillance of the incidence and distribution of disease has been 
an important function of the US Public Health Service (PHS) since an 
1878 Act of Congress, which authorized the PHS to collect morbidity 
reports. After the Malaria Control in War Areas Program had fulfilled 
its original 1942 objective of reducing malaria transmission, its basic 
tenets were carried forward and broadened by the formation of the 
Communicable Disease Center (CDC) in 1946. CDC was conceived of as a 
well-equipped, broadly staffed agency used to translate facts about 
analysis of morbidity and mortality statistics on communicable diseases 
and through field investigations.
    The surveillance emphasis has shifted as certain diseases have 
declined in incidence, national emergencies have prompted involvement 
in new areas, and other diseases have taken on new aspects. 
Surveillance for the following diseases was approved three years ago: 
Creutzfeldt-Jakob Disease (CJD), Cyclosporiasis cayetanensis, Q Fever, 
Dengue, Reye Syndrome, Hantavirus pulmonary syndrome (HPS), Tick-borne 
Rickettsial Disease, Kawasaki syndrome, Trichinosis, Legionellosis, 
Tularemia, Lyme Disease (LD), Typhoid Fever, Malaria, Viral Hepatitis, 
and Plague. Due to change requests and surveillance systems moving to 
and receiving information collection approval under OMB Control number 
0920-0728 (National Notifiable Diseases Surveillance System (NNDSS)) 
during the last three years, the following diseases/conditions are now 
included in this program: Creutzfeldt-Jakob Disease (CJD), Reye 
Syndrome, Kawasaki syndrome, and Acute Flaccid Myelitis. CDC needs to 
continue this surveillance package for another three years to maintain 
continuity in these surveillance systems. The data throughout the years 
are used to monitor the occurrence of non-notifiable conditions and to 
plan and conduct prevention and control programs at the state, 
territorial, local and national levels.
    CDC currently collects data for certain diseases in summary form 
under OMB Control number 0920-0004, (National Disease Surveillance 
Program II--Disease Summaries). These disease summaries are for 
important, yet different types of infections from those covered in this 
disease case reports request. Maintaining separate OMB Control number 
approvals for these two types of data collections assists CDC in 
managing the two surveillance activities.
    CDC works with state health departments to propose, coordinate, and 
evaluate nationwide surveillance systems. State epidemiologists are 
responsible for the collection, interpretation, and transmission of 
medical and epidemiological information to CDC.
    The original purpose for reporting communicable diseases was to 
determine the prevalence of diseases dangerous to public health. 
However, collecting data also provided the basis for planning and 
evaluating effective programs for prevention and control of infectious 
diseases. Current information on disease incidence is needed to study 
present and emerging disease problems. CDC coordination of nationwide 
reporting maintains uniformity so that comparisons can be made from 
state to state and year to year.
    In addition to development of prevention and control programs, 
surveillance data serves as statistical material for those engaged in 
research or medical practice, aid to health education officials and 
students, and data for manufacturers of pharmaceutical products. Annual 
surveillance data are published in the MMWR Surveillance Summary. The 
total burden requested is 190 hours, a decrease in 11,257 hours since 
the last submission. This is due to the other diseases reporting moving 
to the Notifiable Diseases Surveillance System (0920-0728). There is no 
cost to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response (in
                                                                                    respondent         hrs.)
----------------------------------------------------------------------------------------------------------------
Epidemiologist........................  CJD.....................              20               2           20/60
Epidemiologist........................  Kawasaki Syndrome.......              55               8           15/60
Epidemiologist........................  Reye Syndrome...........              50               1           20/60
Epidemiologist........................  Acute Flaccid Myelitis..             100               1           30/60
                                                                 -----------------------------------------------
    Total.............................  ........................  ..............  ..............  ..............
----------------------------------------------------------------------------------------------------------------


Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-31706 Filed 12-16-15; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.